- ongoing, recruitingTherapeutic exploratory (Phase II)
Efficacy and tolerability of tasipimidine after 3 repeated bed-time doses in patients with insomnia disorder with a 4-week extension part
This study is testing a new liquid medicine, tasipimidine, to see if it helps people with insomnia sleep better. Researchers are checking how well it works and if it has any side effects, particularly how it affects waking up during the night and how long it takes to fall asleep.
Finland · Poland · Germany - recruitingPHASE3
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
This study is looking at a new medicine called tasimelteon to see if it helps children and teenagers aged 2 to 17 with sleep problems. Scientists want to know if it works and if it's safe compared to a dummy medicine.
United States · Germany · Poland - recruitingNA
Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia
This study looks at how well a talking therapy (CBT-I) and a new sleeping tablet (lemborexant) work for long-term sleep problems, especially for people also feeling anxious or low. It compares them to a dummy pill to see which helps sleep and mood most.
Canada - ongoing, recruitingTherapeutic exploratory (Phase II)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography, dosefinding study assessing the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to < 18 years with insomnia disorder
This study is looking at a new sleep medicine, daridorexant (also known as QUVIVIQ), for young people aged 10-17 who have trouble sleeping (insomnia). It aims to find the right dose and see how well and safely it works to improve sleep.
Germany · Bulgaria · Spain